A world leading regarding the adequacy of its supply chain security and resilience strategies. The company required an upgrade to its global crisis management and business resilience program to achieve its commercial objectives.

• Lack of Vision: The company struggled with developing a coherent strategy to grow its global crisis management team.
• Inadequate Framework: The existing crisis management framework was insufficient for a company aiming to scale up operations, leaving multiple security gaps.

Sibylline performed a comprehensive gap analysis of the client’s business resilience strategy across its global operations. This involved an initial benchmarking exercise, scoping, and information collection from internal departments and stakeholders. We assessed internal processes and evaluated the crisis management capabilities of departmental focal points, who were non-security professionals. Additionally, Sibylline gathered feedback through a tailored benchmarking questionnaire distributed via corporate security networks.

• Strategic Recommendations: Sibylline provided senior leadership with innovative recommendations focused on enhancing staff skillsets and optimising the use of Enterprise Risk Management Systems and internal policies.
• Redesigned Crisis Management Handbook: We revamped the internal crisis management handbook to align with the new resilience framework.
• Targeted Training Programs: Tailored training programs were developed to ensure the effective implementation of the new crisis management strategies, enabling the client to address security gaps and expand its global crisis management team.

Sibylline’s strategic approach and expert recommendations enabled the pharmaceutical company to fortify its crisis management and resilience framework. This case highlights the importance of tailored consulting services in helping organisations adapt to new risks and scale their operations securely and effectively.